Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ginkgo Bioworks Hldgs Inc
(NY:
DNA
)
0.2340
+0.0125 (+5.64%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ginkgo Bioworks Hldgs Inc
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Dyadic Intl. Inc. (NASDAQ: DYAI) Potential Strategic Alliances with Future of Foods Boosts Stock as Key Conference Looms
March 19, 2024
Via
AB Newswire
Topics
Supply Chain
Exposures
Supply Chain
Is Ginkgo Bioworks Stock a Buy?
March 15, 2024
There's a lot to like about this business, but it's still a risky bet.
Via
The Motley Fool
3 Pharmaceutical Stocks to Buy Hand Over Fist in March
March 11, 2024
There are some great companies at attractive prices in the lucrative pharmaceutical space.
Via
The Motley Fool
Is Ginkgo Bioworks Destined to Be in a "Magnificent Seven" of Healthcare Stocks?
March 03, 2024
It isn't ready for membership today, but it could have a path in the future.
Via
The Motley Fool
S&P 500, Nasdaq 100 Hit Record Highs As Dollar, Treasury Yields Weaken, Chipmakers Shine, NYCB Sinks: What's Driving Markets Friday?
March 01, 2024
March began on a high note on Wall Street, with tech stocks driving indices to record levels. Despite weak data and mixed Fed remarks, investors remain optimistic. Semiconductor industry continues to...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Why Ginkgo Bioworks Stock Is Sinking Today
March 01, 2024
There wasn't much to like in Ginkgo's Q4 update.
Via
The Motley Fool
Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 01, 2024
Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results.
Via
Benzinga
Why Ginkgo Bioworks Stock Is Down After Earnings
March 01, 2024
Ginkgo said the decrease in sales was primarily driven by the expected ramp down of K-12 testing in Ginkgo's Biosecurity segment and the impact of Cell Engineering downstream value share from equity...
Via
Benzinga
Hewlett Packard Enterprise Posts Mixed Q1 Results, Joins Fisker, Plug Power And Other Big Stocks Moving Lower In Friday's Pre-Market Session
March 01, 2024
U.S. stock futures were lower this morning, with the Dow futures trading lower by around 100 points on Friday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Earnings Scheduled For February 29, 2024
February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
Via
Benzinga
Earnings Outlook For Ginkgo Bioworks Holdings
February 28, 2024
Via
Benzinga
Is Ginkgo Bioworks Stock a Buy Now?
February 24, 2024
Ginkgo Bioworks says it is experiencing strong growth from its biopharma customers.
Via
The Motley Fool
bit.bio Announced as Inaugural Partner of Ginkgo Bioworks’ New Technology Network
February 28, 2024
From
bit.bio
Via
Business Wire
2 Top Biotech Stocks That Wall Street Thinks Could Soon Double in Value
February 23, 2024
These two businesses have viable paths to making investors richer -- possibly soon.
Via
The Motley Fool
7 Stocks Cathie Wood Is Still Loading Up On in Q1
February 13, 2024
You won't find many timid bets among the Cathie Wood stocks she believes will dramatically alter our future.
Via
InvestorPlace
2 Cathie Wood Stocks With Jaw-Dropping Growth Potential
February 08, 2024
These two platform biotechs could revolutionize the field of biologically based products.
Via
The Motley Fool
Cathie Wood Just Bought These 3 Biotech Stocks. Should You?
February 07, 2024
They aren't all long shots, but they're all innovative.
Via
The Motley Fool
Evaluating Ginkgo Bioworks Holdings: Insights From 4 Financial Analysts
January 23, 2024
Via
Benzinga
Not Shy Of Buying The Dip, Cathie Wood's Ark Mops Up Over $11M Worth Of Shares In Tesla — Sells Nvidia Stock
February 05, 2024
Via
Benzinga
Cathie Wood's Ark Loads Up On $3.3M Worth Of Robinhood Shares, Continues Its Tesla Stock Purchase Spree
January 31, 2024
Via
Benzinga
Cathie Wood Goes Bargain Hunting: 3 Stocks She Bought Last Week
January 28, 2024
Wood added to her existing positions in these three exciting companies.
Via
The Motley Fool
2 Growth Stocks That Could Rocket 144% and 202% Higher This Year, According to Wall Street
January 27, 2024
Expectations for these stocks are sky-high, but so are the risks.
Via
The Motley Fool
3 Healthcare Stocks at 52-Week Lows: Buy or Bye?
January 26, 2024
Investors should consider picking up these healthcare stocks at 52-week lows to benefit from their potential rebound.
Via
InvestorPlace
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought This Week
January 25, 2024
The widely followed growth stock investor is adding to some of her holdings this week.
Via
The Motley Fool
NuStar Energy, Spirit Airlines, Fastly And Other Big Stocks Moving Higher On Monday
January 22, 2024
U.S. stocks traded higher, with the Dow Jones index gaining around 200 points on Monday. Shares of NuStar Energy L.P. (NYSE: NS) rose sharply during Monday’s session after Sunoco announced it will...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Cathie Wood's Ark Invest Sells $8.04M Worth of DraftKings Shares
January 17, 2024
Via
Benzinga
3 Pricey Stocks I'll Be Watching Like a Hawk in 2024
January 14, 2024
Good things come to those who wait.
Via
The Motley Fool
Flexsteel Industries Posts Strong Preliminary Results, Joins Wipro, Sify Technologies And Other Big Stocks Moving Higher In Friday's Pre-Market Session
January 12, 2024
U.S. stock futures were mixed this morning, with the Dow futures gaining around 50 points on Friday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Analyst Assesses Cell-Programming Focused Ginkgo Bioworks' Positioning Amid Revenue Surge, Program Adjustments
January 10, 2024
Wednesday, Ginkgo Bioworks Holdings Inc (NYSE: DNA) released preliminary FY23 sales of $250 million-$260 million, compared to the consensus of $258.65 million.
Via
Benzinga
3 Cathie Wood Stocks to Start Off Your New Year Right
January 10, 2024
The following stocks could deliver big gains over time.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.